Clarification on Investor Queries relating to profit attributable to owners of the Company and minority interest for the Quarter ended 31st March 2026
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Entero Healthcare Solutions has clarified investor concerns about Q4 FY2026 financial results. The company explained that profit attributable to owners was impacted by INR 114 million in one-off costs, including business contract closure expenses and higher provisioning charges and write-offs from standalone financials and wholly owned subsidiaries. Separately, the increase in non-controlling interest was attributed to the acquisition of Anand Chemiceutics Private Limited during the quarter, where Entero holds a 51.51% stake, resulting in a higher share of profits being allocated to minority shareholders in consolidated financial statements.
The clarification provides transparency on one-time cost impacts affecting profitability and explains the accounting impact of a recent acquisition on minority interest allocation. This should help investors understand the underlying business performance separate from one-off items.